Volume 22 (2023)
Volume 21 (2022)
Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Low-dose versus standard-dose alteplase for intravenous thrombolysis in patients with acute ischemic stroke in Iran: Results from the safe implementation of treatments in stroke registry

Elyar Sadeghi-Hokmabadi; Abdoreza Ghoreishi; Reza Rikhtegar; Payam Sariaslani; Shahram Rafie; Alireza Vakilian; Ehsan Sharifipour; Masoud Mehrpour; Mohammad Saadatnia; Mohammad Mirza-Aghazadeh-Attari; Mehdi Farhoudi

Volume 20, Issue 4 , October 2021, , Pages 208-213


  Background: Rates of intracranial hemorrhage (ICH) after intravenous thrombolysis (IVT) differ depending on ethnicity, one reason that few Eastern countries have approved a lower dose of alteplase. Data in this regard are scarce in the Middle Eastern region. Methods: The present retrospective study ...  Read More

Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients

Elyar Sadeghi-Hokmabadi; Mohammad Yazdchi; Mehdi Farhoudi; Homayoun Sadeghi; Aliakbar Taheraghdam; Reza Rikhtegar; Sahar Mohammadi-Fallah; Rogayyeh Asadi; Elham Mehdizadeh-Far; Neda Ghaemian

Volume 17, Issue 1 , January 2018, , Pages 31-37

  Background: Tissue plasminogen activator (tPA) has been long approved as an efficacious treatment in patients with acute ischemic stroke (AIS); however, due to some serious complications, particularly intracranial hemorrhage (ICH), many physicians are still reluctant to use it liberally. This study sought ...  Read More

Predicting 30-day mortality in patients with primary intracerebral hemorrhage (ICH): Evaluation of the value of intracerebral hemorrhage and modified new intracerebral hemorrhage scores

Farzad Rahmani; Reza Rikhtegar; Alireza Ala; Aysan Farkhad-Rasooli; Haniyeh Ebrahimi-Bakhtavar

Volume 17, Issue 1 , January 2018, , Pages 47-52

  Background: Different criteria have been proposed to determine the mortality rate of primary intracerebral hemorrhage (ICH). This study aimed to evaluate ICH and Modified New ICH scores in predicting 30-day mortality in patients with primary ICH.Methods: In this prospective cohort study, 107 patients ...  Read More

Stroke subtypes, risk factors and mortality rate in northwest of Iran

Mehdi Farhoudi; Homayoun Sadeghi-Bazargani; Mazyar Hashemilar; Manouchehr Seyedi-Vafaee; Elyar Sadeghi-Hokmabad; Reza Rikhtegar; Babak Saber-Maroof; Mohammad Abutalebi; Mahsa Rezaei; Sahar Vaferi; Alireza Aghili; Omid Ebrahimi; Alireza Majdi; Mohammad Hasan Mokhtare; Hadiseh Kavandi; Hadi Ahmadi; Ramak Barnous

Volume 16, Issue 3 , July 2017, , Pages 112-117

  Background: Stroke is the second most common cause of death and first cause of disability in adults in the world. About 80% of all stroke deaths occur in developing countries. So far, the data on stroke epidemiology have been limited in Iran. Therefore, this study was focused on stroke demographic data, ...  Read More

Acute management of stroke in Iran: Obstacles and solutions

Shima Shahjouei; Reza Bavarsad-Shahripour; Farhad Assarzadegan; Reza Rikhtegar; Masoud Mehrpour; Babak Zamani; Georgios Tsivgoulis; Andrei Alexandrov; Anne Alexandrov; Ramin Zand

Volume 16, Issue 2 , April 2017, , Pages 62-71

  Background: Stroke is among the leading causes of mortality and permanent disability in the world. Iran is located in the stroke belt and has a high age-adjusted stroke incidence rate. In this multistep prospective qualitative study, we aimed at investigating the status and challenges of stroke management ...  Read More